Open Call FETOPEN-01-2016-2017: FET-Open Research and Innovation Actions

European CommissionThe successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas. Here agile, risk-friendly and highly interdisciplinary research approaches are needed with collaborations that are open to all sciences and disciplines and that dissolve the traditional boundaries between them. The renewal of ideas is complemented by the renewal of actors taking these new ideas forward. Therefore, this topic encourages the driving role of new high-potential actors in research and innovation, such as excellent young, both female and male, researchers and high-tech SMEs that may become the scientific and industrial leaders of the future.

This topic supports the early stages of research to establish a new technological possibility. Proposals are sought for collaborative research with all of the following characteristics ('FET gatekeepers'):

  • Long-term vision: the research proposed must address a new and radical long-term vision of a science- and technology-enabled future that is far beyond the state of the art and not currently foreseen by technology roadmaps.
  • Breakthrough scientific and technological target: research must target a scientifically ambitious and technologically concrete breakthrough, argued to be a crucial step towards achieving the long-term vision. The plausibility of the proposed breakthrough(s) to be attained within the life-time of the project must be argued in the proposal.
  • Novelty: the research proposed for achieving the breakthrough must be based on cutting-edge knowledge, new ideas and concepts, rather than in the mere application or incremental refinement of existing ones.
  • Foundational: the breakthroughs that are envisaged must be foundational in the sense that, if achieved, they would establish an essential basis for a new kind of technology and its future uses, not currently anticipated.
  • High-risk: the inherently high risk of the research proposed will be reflected in a flexible but effective methodology for exploring alternative directions and options, supported by open and agile research and innovation practices.
  • Interdisciplinary: the proposed collaborations are expected to go beyond 'waterfall' configurations in multi-disciplinary science- and technology research. Instead they should seek new solutions through genuine exchanges, mutual learning, cross-fertilisation and synergistic advances among distant disciplines in order to open unexplored areas of investigation and new directions for joint research.

The Commission considers that proposals requesting a contribution from the EU of up to EUR 3 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Deadline Model: multiple cut-off

Cut-off dates:
11 May 2016 17:00:00
17 January 2017 17:00:00
27 September 2017 17:00:00

Type of action: RIA Research and Innovation action.

For topic conditions, documents and submission service, please visit:
http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/fetopen-01-2016-2017.html

PS: Find your partners or consortia preparing a project proposal
If you are working on Horizon 2020 research project proposals and you would be interested in a SME partner from Germany, please contact us, we are happy to share our experience, expertise and knowledge. If you need help to identify a potential partner with particular competences, facilities or experience, please join and explore our project, (HEALTH IT) SPACE, at www.healthitspace.eu.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...